BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19775334)

  • 1. Targeted tailored management of the breast cancer patient at risk for harboring a germline mutation-current trends affecting the selection of patients considering surgical prophylaxis for breast cancer.
    Silva E
    Breast J; 2009; 15 Suppl 1():S76-80. PubMed ID: 19775334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic mastectomy and genetic testing: an update.
    Houshmand SL; Campbell CT; Briggs SE; McFadden AW; Al-Tweigeri T
    Oncol Nurs Forum; 2000; 27(10):1537-47; quiz 1548-9. PubMed ID: 11103373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can genetic testing guide treatment in breast cancer?
    Tutt A; Ashworth A
    Eur J Cancer; 2008 Dec; 44(18):2774-80. PubMed ID: 19027287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations.
    Silva E; Lynch H
    Breast J; 2006; 12(3):280-1; author reply 282-4. PubMed ID: 16684334
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hereditary breast cancer: treatment and prevention].
    Ejlertsen B; Gerdes AM
    Ugeskr Laeger; 2007 Sep; 169(36):2972-5. PubMed ID: 17953871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the BRCA mutation carrier or high-risk patient.
    Bordeleau LJ; Lipa JE; Neligan PC
    Clin Plast Surg; 2007 Jan; 34(1):15-27; abstract v. PubMed ID: 17307068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylactic mastectomies and immediate breast reconstruction in patients at very high genetic risk: our experience with 14 cases].
    Missana MC; Chompret A
    Ann Chir Plast Esthet; 2008 Aug; 53(4):325-33. PubMed ID: 18055089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Best surgical prophylaxis--risk-reducing mastectomy for women at high personal risk of breast cancer.
    Baildam AD
    Breast; 2006 Dec; 15 Suppl 2():S21-5. PubMed ID: 17382857
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylactic mastectomy.
    Zakaria S; Degnim AC
    Surg Clin North Am; 2007 Apr; 87(2):317-31, viii. PubMed ID: 17498529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of hereditary breast cancer.
    Rodriquez E; Domchek SM
    Semin Oncol; 2007 Oct; 34(5):401-5. PubMed ID: 17920894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral Prophylactic Mastectomy Overtreatment: Expectations from Personal Genomics for Tailored Breast Cancer Surgery.
    Zografos GC; Roukos DH
    Ann Surg Oncol; 2010 Mar; 17(3):939; author reply 940. PubMed ID: 19937131
    [No Abstract]   [Full Text] [Related]  

  • 14. Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret.
    van Dijk S; van Roosmalen MS; Otten W; Stalmeier PF
    J Clin Oncol; 2008 May; 26(14):2358-63. PubMed ID: 18467728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI in breast cancer management: potential for benefit and harm.
    Jatoi I
    Int J Fertil Womens Med; 2005; 50(6):281-4. PubMed ID: 16526420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic counseling and the advanced practice oncology nursing role in a hereditary cancer prevention clinic: hereditary breast cancer focus (part II).
    Lynch HT; Snyder CL; Lynch JF
    Breast J; 2009; 15 Suppl 1():S11-9. PubMed ID: 19775324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lesser evil: prophylactic mastectomy for women at high risk for breast cancer.
    Schover LR
    J Clin Oncol; 2008 Aug; 26(24):3918-9. PubMed ID: 18711178
    [No Abstract]   [Full Text] [Related]  

  • 18. MR imaging for surveillance of women at high familial risk for breast cancer.
    Kuhl CK
    Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):391-402, vii. PubMed ID: 17098180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic counseling and the advanced practice oncology nursing role in a hereditary cancer prevention clinic: hereditary breast cancer focus (part I).
    Snyder CL; Lynch JF; Lynch HT
    Breast J; 2009; 15 Suppl 1():S2-10. PubMed ID: 19775325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary breast and ovarian cancer syndrome.
    ACOG Committee on Practice Bulletins
    Gynecol Oncol; 2009 Apr; 113(1):6-11. PubMed ID: 19309638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.